stockportfolio.pro
ANI Pharmaceuticals, Inc. Gross Profit 2009–2025
ANI Pharmaceuticals, Inc. (ANIP) annual gross profit by fiscal year, computed from SEC filings. Compound growth +16.1%/yr over 16 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | — | — | — |
| FY 2024 | — | — | — |
| FY 2023 | — | — | — |
| FY 2022 | — | — | — |
| FY 2021 | — | — | — |
| FY 2020 | $121.32M | 58.2% | -15.4% |
| FY 2019 | $143.39M | 69.4% | +11.5% |
| FY 2018 | $128.55M | 63.8% | +31.4% |
| FY 2017 | $97.81M | 55.3% | +22.5% |
| FY 2016 | $79.84M | 62.1% | +25.5% |
| FY 2015 | $63.63M | 83.4% | +43.0% |
| FY 2014 | $44.50M | 79.5% | +121.3% |
| FY 2013 | $20.11M | 66.8% | +79.5% |
| FY 2012 | $11.20M | 55.0% | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
Source: ANI Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for ANI Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeANI Pharmaceuticals, Inc. — frequently asked questions
What is ANI Pharmaceuticals, Inc.'s gross profit?
ANI Pharmaceuticals, Inc. (ANIP) reported gross profit of $121.32M for fiscal year 2020, per its SEC filings.
How has ANI Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, ANIP's gross profit grew at roughly 16.1% per year (compound annual rate), from $11.20M to $121.32M.
Where does this data come from?
Figures are computed from ANI Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.